SPRAVATO® Benefits: The Science of Hope for Treatment-Resistant Depression
For patients struggling with treatment-resistant depression (TRD), finding relief can feel like chasing a distant dream. Traditional oral antidepressants, while effective for many, don’t work for everyone. That’s where SPRAVATO, a groundbreaking esketamine nasal spray, steps in—a revolutionary treatment designed to address depression in a fundamentally different way. SPRAVATO is FDA-approved to treat depression in … SPRAVATO® Benefits: The Science of Hope for Treatment-Resistant Depression
